Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: A meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 4, 2014, Pages 688-696

  Qi, Xingshun ^a,b   Liu, Lei ^a   Bai, Ming ^a   Chen, Hui ^a   Wang, Juan ^b   Yang, Zhiping ^a   Han, Guohong ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 463 Hospital of Chinese PLA   (China)

Author keywords

Meta analysis; Transjugular intrahepatic portosystemic shunt; Variceal bleeding; Variceal embolization

Indexed keywords

ALCOHOL; CYANOACRYLATE DERIVATIVE; SCLEROSING AGENT;

ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; CASE STUDY; CHILD PUGH SCORE; DEATH; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICEAL REBLEEDING; VARICOSIS;

META-ANALYSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICEAL BLEEDING; VARICEAL EMBOLIZATION;

DATABASES, BIBLIOGRAPHIC; EMBOLIZATION, THERAPEUTIC; HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; INCIDENCE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; VARICOSE VEINS;

EID: 84896329483     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12391     Document Type: Article

References (39)

1. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J. Vasc. Interv. Radiol. 2005; 16: 615-629.
2. Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig. Liver Dis. 2010; 42: 462-467.
3. Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin. Gastroenterol. Hepatol. 2011; 9: 936-946; quiz e123.
4. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-938.
5. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 2010; 53: 397-417.
6. Garcia-Pagan JC, Caca K, Bureau C etal. Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 2010; 362: 2370-2379.
7. Corbett C, Mangat K, Olliff S, Tripathi D. The role of transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of variceal hemorrhage. Liver Int. 2012; 32: 1493-1504.
8. Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand. J. Gastroenterol. 2013; 48: 771-784.
9. Garcia-Pagan JC, Heydtmann M, Raffa S etal. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135: 808-815.
10. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004; 135: 394-403.
11. Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol. Int. 2012; 6: 576-590.
12. Fanelli F, Angeloni S, Salvatori FM etal. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Dig. Liver Dis. 2011; 43: 78-84.
13. Luca A, Miraglia R, Caruso S etal. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 60: 846-852.
14. Qi X, Han G, Yin Z etal. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig. Dis. Sci. 2012; 57: 1072-1082.
15. Dhanasekaran R, West JK, Gonzales PC etal. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am. J. Gastroenterol. 2010; 105: 635-641.
16. Bureau C, Garcia-Pagan JC, Otal P etal. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469-475.
17. Yang Z, Han G, Wu Q etal. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J. Gastroenterol. Hepatol. 2010; 25: 1718-1725.
18. Chen L, Xiao T, Chen W etal. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial. Liver Int. 2009; 29: 1101-1109.
19. Smith-Laing G, Scott J, Long RG, Dick R, Sherlock S. Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology 1981; 80: 1031-1036.
20. Takase Y, Shibuya S, Chikamori F, Orii K, Iwasaki Y. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices. Hepatology 1990; 11: 348-352.
21. Gaba RC, Bui JT, Cotler SJ etal. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization. Hepatol. Int. 2010; 4: 749-756.
22. Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 2005; 236: 360-367.
23. Chen S, Li X, Wei B etal. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 2013; 268: 900-906.
24. Xiao T, Chen L, Chen W etal. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J. Clin. Gastroenterol. 2011; 45: 643-650.
25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009; 151: 264-269, W64.
26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959; 22: 719-748.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
29. Gaba RC, Omene BO, Podczerwinski ES etal. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J. Vasc. Interv. Radiol. 2012; 23: 227-235.
30. Tripathi D, Lui HF, Helmy A etal. Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut 2004; 53: 431-437.
31. Wei B, Chen S, Li X, Tang CW. Prevention of variceal rebleeding by TIPS combined with embolization of gastric coronary veins: a clinical controlled study. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin. J. Hepatol. 2011; 19: 494-497.
32. Wu XJ, Cao JM, Han JM, Li JS. Long-term results of TIPS, TIPS with CVO and combined TIPS and portal azygous disconnection for the treatment of portal hypertension. Zhonghua wai ke za zhi [Chin. J. Surg.] 2009; 47: 446-449.
33. Xue H, Yuan J, Chao-Li Y etal. Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Dig. Dis. Sci. 2011; 56: 3350-3356.
34. Kakutani H, Hino S, Ikeda K etal. Prediction of recurrence of esophageal varices-special reference to a role for endoscopic ultrasonography. Hepatol. Res. 2005; 33: 259-266.
35. Lo GH, Lai KH, Cheng JS, Huang RL, Wang SJ, Chiang HT. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest. Endosc. 1999; 49: 428-436.
36. Cura M, Cura A, Suri R, El-Merhi F, Lopera J, Kroma G. Causes of TIPS dysfunction. AJR Am. J. Roentgenol. 2008; 191: 1751-1757.
37. Madoff DC, Wallace MJ, Ahrar K, Saxon RR. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics 2004; 24: 21-36; discussion -7.
38. Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin. Liver Dis. 2012; 16: 133-146.
39. He C, Qi X, Han G. Large paraesophageal varices causing recurrent hepatic encephalopathy. Am. J. Med. Sci. 2013 (in press).